Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia.

Current drug targets - 1 Jan 2017

Goswami Meghali, Hourigan Christopher S

Abstract excerpt

Acute myeloid leukemia (AML) was the first malignancy for which immunotherapy, in the form of allogeneic hematopoietic stem cell transplantation (allo-HSCT), was integrated into the standard of care. Allo-HSCT however is an imperfect therapy associated with significant morbidity and mortality while offering only incomplete prevention of AML clinical relapse. These limitations have motivated the search for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Biomarkers, Tumor
Share to Carbohydrates

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Hematopoietic Stem Cell Transplantation

Share to Immunotherapy

Share to Leukemia, Myeloid, Acute

Share to Protein Processing, Post-Translational

Source

Open in PubMed Open full text

Identifiers

PMID: 25706110
DOI: 10.2174/1389450116666150223120005
PMCID: PMC6321986

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia.PMID 25706110Read ↗

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?Semantic proximity Read ↗

Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes.Semantic proximity Read ↗

Identification of specific T-cell response and T-cell receptor targeting shared neoantigen for acute myeloid leukemia.Semantic proximity Read ↗

Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia.Semantic proximity Read ↗

Identification of human tumor antigens and its implications for diagnosis and treatment of cancerSemantic proximity Read ↗

CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.Semantic proximity Read ↗

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapySemantic proximity Read ↗

Minor Histocompatibility AntigensSemantic proximity Read ↗

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.Semantic proximity Read ↗

The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processedSemantic proximity Read ↗

Oncogenic proteins as tumor antigens.Semantic proximity Read ↗

Shared Graft Versus Leukemia Minor Histocompatibility Antigens in DISCOVeRY-BMTSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.